Synthomer (SYNT) Competitors GBX 63 -0.30 (-0.47%) As of 12:13 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock SYNT vs. ESNT, ZTF, TET, IOF, HAYD, WCH, ITX, DCTA, HDD, and BIOMShould you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), and Biome Technologies (BIOM). These companies are all part of the "specialty chemicals" industry. Synthomer vs. Its Competitors Essentra Zotefoams Treatt Iofina Haydale Graphene Industries Wilmcote Holdings plc (WCH.L) Itaconix Directa Plus Hardide Biome Technologies Essentra (LON:ESNT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Which has more risk & volatility, ESNT or SYNT? Essentra has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500. Do institutionals & insiders hold more shares of ESNT or SYNT? 69.5% of Essentra shares are owned by institutional investors. Comparatively, 18.8% of Synthomer shares are owned by institutional investors. 0.5% of Essentra shares are owned by company insiders. Comparatively, 5.0% of Synthomer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable valuation & earnings, ESNT or SYNT? Essentra has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEssentra£295.10M0.95£3.50M£0.032,972.73Synthomer£1.89B0.05-£82.04M-£0.51-123.29 Does the media favor ESNT or SYNT? In the previous week, Essentra and Essentra both had 1 articles in the media. Essentra's average media sentiment score of 0.59 beat Synthomer's score of -0.97 indicating that Essentra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Essentra 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Synthomer 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Do analysts recommend ESNT or SYNT? Essentra presently has a consensus target price of GBX 191.67, suggesting a potential upside of 95.38%. Synthomer has a consensus target price of GBX 142.50, suggesting a potential upside of 126.19%. Given Synthomer's higher probable upside, analysts plainly believe Synthomer is more favorable than Essentra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Essentra 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Synthomer 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is ESNT or SYNT more profitable? Essentra has a net margin of 1.13% compared to Synthomer's net margin of -4.40%. Essentra's return on equity of 1.28% beat Synthomer's return on equity.Company Net Margins Return on Equity Return on Assets Essentra1.13% 1.28% 1.74% Synthomer -4.40%-7.52%-0.28% SummaryEssentra beats Synthomer on 11 of the 15 factors compared between the two stocks. Get Synthomer News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYNT vs. The Competition Export to ExcelMetricSynthomerSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£102.99M£7.42B£3.56B£2.56BDividend Yield28.47%3.50%5.06%5.31%P/E Ratio-123.29618.83156.715,410.43Price / Sales0.0596.2918,007.6397,367.82Price / Cash2.2819.2525.7427.93Price / Book0.092.586.499.45Net Income-£82.04M£220.83M£149.31M£5.89B7 Day Performance6.96%-1.24%2.01%0.45%1 Month Performance-7.35%-3.01%10.57%44.44%1 Year Performance-71.03%-8.04%46.27%186.28% Synthomer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYNTSynthomer2.4565 of 5 starsGBX 63-0.5%GBX 142.50+126.2%-70.6%£102.99M£1.89B-123.294,200ESNTEssentra2.945 of 5 starsGBX 95.10-3.2%GBX 191.67+101.5%-40.9%£271.15M£295.10M2,881.82350Positive NewsZTFZotefoams3.0572 of 5 starsGBX 392-1.3%GBX 540+37.8%-10.8%£191.01M£154.16M34,086.96549TETTreatt0.7241 of 5 starsGBX 263-0.8%GBX 386.67+47.0%-40.1%£155.05M£145.16M1,434.02350News CoverageDividend IncreaseAnalyst DowngradeHigh Trading VolumeIOFIofinaN/AGBX 24.60+0.4%GBX 37.50+52.4%+11.0%£47.20M£54.47M1,640.0095Gap DownHAYDHaydale Graphene IndustriesN/AGBX 0.53+5.0%N/A+103.4%£22.70M£3.61M-159.0967Gap UpWCHWilmcote Holdings plc (WCH.L)N/AN/AN/AN/A£20.13MN/A-5.003ITXItaconix1.6833 of 5 starsGBX 130-1.9%GBX 325+150.0%-18.0%£17.53M£6.50M-942.0317News CoverageEarnings ReportAnalyst ForecastDCTADirecta PlusN/AGBX 11+4.8%N/A-24.1%£11.49M£6.66M-183.33187Gap DownHDDHardideN/AGBX 7.90-1.3%N/A+28.7%£6.23M£5.42M-1,974.5046BIOMBiome TechnologiesN/AGBX 6.80+2.4%N/A+32.4%£3.51M£5.75M-20.0027 Related Companies and Tools Related Companies Essentra Alternatives Zotefoams Alternatives Treatt Alternatives Iofina Alternatives Haydale Graphene Industries Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Itaconix Alternatives Directa Plus Alternatives Hardide Alternatives Biome Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SYNT) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthomer plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synthomer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
